Q1 EPS Estimates for CVS Health Raised by Leerink Partnrs

CVS Health Co. (NYSE:CVS) – Research analysts at Leerink Partnrs raised their Q1 2025 EPS estimates for shares of CVS Health in a research report issued to clients and investors on Wednesday, February 12th. Leerink Partnrs analyst M. Cherny now expects that the pharmacy operator will earn $1.62 per share for the quarter, up from their previous estimate of $1.20. Leerink Partnrs has a “Strong-Buy” rating on the stock. The consensus estimate for CVS Health’s current full-year earnings is $5.14 per share. Leerink Partnrs also issued estimates for CVS Health’s Q2 2025 earnings at $1.61 EPS, Q3 2025 earnings at $1.28 EPS, Q4 2025 earnings at $1.37 EPS, FY2025 earnings at $5.88 EPS and FY2026 earnings at $7.16 EPS.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%.

CVS has been the topic of a number of other reports. Evercore ISI upped their target price on shares of CVS Health from $60.00 to $65.00 and gave the stock an “outperform” rating in a research note on Monday, January 27th. JPMorgan Chase & Co. upped their target price on shares of CVS Health from $80.00 to $81.00 and gave the stock an “overweight” rating in a research note on Tuesday. Mizuho dropped their target price on shares of CVS Health from $73.00 to $66.00 and set an “outperform” rating on the stock in a research note on Thursday, October 24th. Wolfe Research upped their target price on shares of CVS Health from 67.00 to 70.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 11th. Finally, Cantor Fitzgerald upgraded shares of CVS Health from a “neutral” rating to an “overweight” rating in a research note on Wednesday, February 12th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $70.00.

CVS Health Stock Performance

Shares of NYSE:CVS opened at $65.47 on Monday. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. The company has a market capitalization of $82.39 billion, a price-to-earnings ratio of 16.62, a PEG ratio of 0.60 and a beta of 0.61. The firm’s 50-day moving average is $51.30 and its 200 day moving average is $56.03. CVS Health has a 12 month low of $43.56 and a 12 month high of $80.75.

CVS Health Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.06%. CVS Health’s dividend payout ratio is currently 67.51%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in CVS. MidAtlantic Capital Management Inc. purchased a new position in shares of CVS Health in the third quarter worth $25,000. Ridgewood Investments LLC raised its holdings in shares of CVS Health by 255.7% in the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock worth $28,000 after buying an additional 450 shares during the last quarter. Stonebridge Financial Group LLC purchased a new position in shares of CVS Health during the fourth quarter worth $28,000. Hopwood Financial Services Inc. purchased a new position in shares of CVS Health during the fourth quarter worth $29,000. Finally, Livelsberger Financial Advisory purchased a new position in shares of CVS Health during the third quarter worth $31,000. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.